More Data on Pregnancy Outcomes Associated with Lithium Use During Pregnancy
Lithium use during pregnancy was associated with an increased risk of preterm birth and large for gestational age infants.
Coach-Supported Web-Based Intervention for Mild to Moderate Postpartum Depression
This preliminary study suggests that web-based interventions with coaching are feasible, acceptable, and potentially effective treatment options for women with mild to moderate postpartum depression and/or anxiety.
Single Day CBT-Based Workshops for Mothers with Postpartum Depression
In this randomized controlled trial, a CBT-based workshop for women with PPD led to clinically meaningful reductions in depression and anxiety.
Recruiting for Research Study: Pregnenolone Neurosteroid for Menopausal Depression
Over the last few years we have heard a great deal about neurosteroids, also known as neuroactive steroids. This class of compounds are steroid hormones produced in the brain and endocrine tissues which can [...]
Weekly Roundup for MAY 5, 2023: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
On Postpartum Psychosis Awareness Day: Educating Mothers, Families, and Health Care Providers
Postpartum psychosis is the most severe form of postpartum psychiatric illness. What are the signs and symptoms?
Transcranial magnetic stimulation during pregnancy: An alternative to antidepressant treatment?
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on transcranial magnetic stimulation during pregnancy with Ob.Gyn News on May 4th.
Zuranolone Improves Anxiety Symptoms and Insomnia in Women with Postpartum Depression
In women with postpartum depression, zuranolone was associated with concurrent improvements in depression, anxiety symptoms, and insomnia beginning at day 3.
Maternal Mental Health Awareness Week: May 1-7, 2023
May 4, 2022 is World Maternal Mental Health Day, coming together to increase awareness of perinatal mood and anxiety disorders.
New Research from the CWMH: More Data on the Reproductive Safety of Lurasidone and Quetiapine
New findings from the National Pregnancy Registry for Atypical Antipsychotics provide reassuring data regarding the safety of prenatal exposure to lurasidone and quetiapine in a sample of well-characterized participants.